Back to Search
Start Over
Nucleophosmin/B23-binding peptide inhibits tumor growth and up-regulates transcriptional activity of p53.
- Source :
-
Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2005 Jul 29; Vol. 333 (2), pp. 396-403. - Publication Year :
- 2005
-
Abstract
- The Rev peptide that binds to nucleophosmin/B23 with the highest affinity exhibited the greatest cytotoxicity on Ras-3T3 cells and inhibited tumor growth most effectively in nude mice. The efficiency of colony formation in soft agar of Ras-3T3 cells was significantly inhibited by treatment with Rev peptide. In addition, Rev peptide could potentiate the doxorubicin-induced decrease of cellular viability in U1 bladder cancer cells and inhibition of tumor growth in nude mice. Treatment of Rev peptide increased protein expression and transcriptional activity of p53 and inhibited the nucleophosmin/B23-mediated PCNA promoter activation. Peptides having high affinity of binding to molecular targets such as nucleophosmin/B23 represent a potentially useful approach to anti-cancer biotherapeutics.
- Subjects :
- Animals
Cell Line, Tumor
Cell Proliferation drug effects
Dose-Response Relationship, Drug
Enzyme Activation drug effects
Mice
Mice, Nude
Nucleophosmin
Transcriptional Activation drug effects
Up-Regulation drug effects
Urinary Bladder Neoplasms drug therapy
Urinary Bladder Neoplasms metabolism
Carcinoma, Transitional Cell drug therapy
Carcinoma, Transitional Cell metabolism
Gene Products, rev administration & dosage
Nuclear Localization Signals administration & dosage
Nuclear Proteins antagonists & inhibitors
Nuclear Proteins metabolism
Peptides administration & dosage
Tumor Suppressor Protein p53 metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 0006-291X
- Volume :
- 333
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Biochemical and biophysical research communications
- Publication Type :
- Academic Journal
- Accession number :
- 15950182
- Full Text :
- https://doi.org/10.1016/j.bbrc.2005.04.176